tag:www.gov.uk,2005:/government/organisations/commission-on-human-medicines Commission on Human Medicines - Activity on 188ĚĺÓý HM Government 2025-01-24T11:56:08Z /government/publications/chms-report-on-proposed-changes-to-the-availability-of-puberty-blockers#2025-01-24T11:56:08Z 2025-01-24T11:56:08Z Independent report: CHM's report on proposed changes to the availability of puberty blockers Independent report by the Commission on Human Medicines on the safety implications of a proposal to restrict the availability of puberty blockers for under 18s. /government/publications/meeting-minutes-of-the-vaccine-benefit-risk-expert-working-group-from-the-covid-19-pandemic-10-may-2021-to-25-may-2021#2024-12-09T00:00:00Z 2024-12-09T00:00:00Z Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 10 May 2021 to 25 May 2021 Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 10 May 2021 to 25 May 2021. /government/publications/meeting-minutes-of-the-vaccine-benefit-risk-expert-working-group-from-the-covid-19-pandemic-13-january-2021-to-15-february-2021#2024-12-09T00:00:00Z 2024-12-09T00:00:00Z Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 13 January 2021 to 15 February 2021 Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 13 January 2021 to 15 February 2021. /government/publications/meeting-minutes-of-the-vaccine-benefit-risk-expert-working-group-from-the-covid-19-pandemic-25-february-2021-to-6-april-2021#2024-12-09T00:00:00Z 2024-12-09T00:00:00Z Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 25 February 2021 to 6 April 2021 Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 February 2021 to 6 April 2021. /government/publications/meeting-minutes-of-the-vaccine-benefit-risk-expert-working-group-from-the-covid-19-pandemic-25-august-2020-to-28-november-2020#2024-12-09T00:00:00Z 2024-12-09T00:00:00Z Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 25 August 2020 to 28 November 2020 Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 August 2020 to 28 November 2020. /government/publications/meeting-minutes-of-the-vaccine-benefit-risk-expert-working-group-from-the-covid-19-pandemic-12-april-2021-to-4-may-2021#2024-12-09T00:00:00Z 2024-12-09T00:00:00Z Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 12 April 2021 to 4 May 2021 Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 12 April 2021 to 4 May 2021. /government/publications/meeting-minutes-of-the-vaccine-benefit-risk-expert-working-group-from-the-covid-19-pandemic-7-december-2020-to-3-january-2021#2024-12-09T00:00:00Z 2024-12-09T00:00:00Z Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 7 December 2020 to 3 January 2021 Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 7 December 2020 to 3 January 2021. /government/news/professor-sir-munir-pirmohamed-appointed-chair-of-chm-for-another-four-years-as-three-commissioners-reappointed#2024-10-30T12:35:17Z 2024-10-30T12:35:17Z Professor Sir Munir Pirmohamed appointed chair of CHM for another four years as three commissioners reappointed The appointment will involve a time commitment of 33 days per year. Remuneration for the role will be at a rate of ÂŁ500 per attendance and preparation for meetings. /government/publications/human-medicines-regulations-2012-advisory-bodies-annual-report-2023#2024-07-30T15:32:41Z 2024-07-30T15:32:41Z Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2023 Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission. /government/publications/report-of-the-commission-on-human-medicines-isotretinoin-implementation-advisory-expert-working-group#2024-02-08T11:00:09Z 2024-02-08T11:00:09Z Research: Report of The Commission on Human Medicines Isotretinoin Implementation Advisory Expert Working Group Report of Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan. /government/publications/use-of-uk-plasma-for-the-manufacture-of-albumins-and-vcjd-risk#2023-08-15T16:22:06Z 2023-08-15T16:22:06Z Research: Use of UK plasma for the manufacture of albumins and vCJD risk The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD. /government/publications/human-medicines-regulations-2012-advisory-bodies-annual-report-2022#2023-07-19T16:34:01Z 2023-07-19T16:34:01Z Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022 Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission. /government/publications/report-of-the-commission-on-human-medicines-isotretinoin-expert-working-group#2023-04-26T10:36:29Z 2023-04-26T10:36:29Z Research: Report of the Commission on Human Medicines Isotretinoin Expert Working Group Report of the Commission on Human Medicines (CHM) Isotretinoin Expert Working Group and plain-language summary of the recommendations. /government/consultations/consultation-on-a-new-code-of-practice-for-the-expert-advisory-committees#2022-09-08T13:31:05Z 2022-09-08T13:31:05Z Consultation on a new Code of Practice for the Expert Advisory Committees We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the advice are independent and impartial, and that the processes in place to manage conflicts of interest are robust and clear to all. /government/news/nine-new-commissioners-appointed-to-the-commission-on-human-medicines#2022-07-28T08:38:00Z 2022-07-28T08:38:00Z Nine new commissioners appointed to the Commission on Human Medicines Nine new commissioners have been appointed to the Commission on Human Medicines to serve for four years, in accordance with the Cabinet Office Code of Governance for Public Appointments. /government/publications/human-medicines-regulations-2012-advisory-bodies-annual-report-2021#2022-07-19T15:38:00Z 2022-07-19T15:38:00Z Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2021 Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission /government/news/life-saving-adrenaline-auto-injectors-could-become-available-in-public-places#2021-11-11T14:59:00Z 2021-11-11T14:59:00Z Life-saving adrenaline auto-injectors could become available in public places The chance for adults and children suffering from life-threatening allergic reactions to get life-saving shots of adrenaline in public places, such as restaurants and entertainment venues, has come a step closer as a result of a report published today by the government’s independent advisory body, the Commission on Human Medicines (CHM). /government/publications/public-assessment-report-recommendations-to-support-the-effective-and-safe-use-of-adrenaline-auto-injectors#2021-11-11T14:55:00Z 2021-11-11T14:55:00Z Research: Public Assessment Report: Recommendations to support the effective and safe use of adrenaline auto-injectors This report provides a combined summary of the conclusions and recommendations of the Commission on Human Medicinesâ€� Adrenaline Auto-injector Expert Working Group to support the effective and safe use of Adrenaline Auto-injectors. /government/publications/human-medicines-regulations-2012-advisory-bodies-annual-report-2020#2021-07-15T13:56:00Z 2021-07-15T13:56:00Z Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2020 Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission /government/news/new-chair-of-the-commission-on-human-medicines#2021-02-12T13:00:04Z 2021-02-12T13:00:04Z New Chair of the Commission on Human Medicines Professor Sir Munir Pirmohamed has been appointed by the Secretary of State for Health and Social Care as Chair of the Commission on Human Medicines (CHM).